受强制性开放获取政策约束的文章 - Jennifer Huellein了解详情
无法在其他位置公开访问的文章:7 篇
Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions in patients with rare cancers
P Horak, C Heining, S Kreutzfeldt, B Hutter, A Mock, J Hüllein, M Fröhlich, ...
Cancer discovery 11 (11), 2780-2795, 2021
强制性开放获取政策: Helmholtz Association
The impact of SF3B1 mutations in CLL on the DNA-damage response
GD te Raa, IAM Derks, V Navrkalová, A Skowronska, PD Moerland, ...
Leukemia 29 (5), 1133-1142, 2015
强制性开放获取政策: Dutch Cancer Society
TP53 mutation and survival in aggressive B cell lymphoma
T Zenz, M Kreuz, M Fuge, W Klapper, H Horn, AM Staiger, D Winter, ...
International Journal of Cancer 141 (7), 1381-1388, 2017
强制性开放获取政策: Canadian Institutes of Health Research
MED12 mutations and NOTCH signalling in chronic lymphocytic leukaemia
B Wu, M Słabicki, L Sellner, S Dietrich, X Liu, A Jethwa, J Hüllein, ...
British journal of haematology 179 (3), 421-429, 2017
强制性开放获取政策: Helmholtz Association
MDM4 is targeted by 1q gain and drives disease in Burkitt lymphoma
J Hüllein, M Słabicki, M Rosolowski, A Jethwa, S Habringer, K Tomska, ...
Cancer research 79 (12), 3125-3138, 2019
强制性开放获取政策: Helmholtz Association, European Commission
Dissection of CD20 regulation in lymphoma using RNAi
M Słabicki, KS Lee, A Jethwa, L Sellner, F Sacco, T Walther, J Hüllein, ...
Leukemia 30 (12), 2409-2412, 2016
强制性开放获取政策: US National Institutes of Health, European Molecular Biology Laboratory …
Phenotypic differentiation does not affect tumorigenicity of primary human colon cancer initiating cells
TD Dubash, CM Hoffmann, F Oppel, KM Giessler, S Weber, SM Dieter, ...
Cancer letters 371 (2), 326-333, 2016
强制性开放获取政策: German Research Foundation, Helmholtz Association
可在其他位置公开访问的文章:23 篇
Targeting the BRAF V600E mutation in multiple myeloma
M Andrulis, N Lehners, D Capper, R Penzel, C Heining, J Huellein, ...
Cancer discovery 3 (8), 862-869, 2013
强制性开放获取政策: US National Institutes of Health
Drug-perturbation-based stratification of blood cancer
S Dietrich, M Oleś, J Lu, L Sellner, S Anders, B Velten, B Wu, J Huellein, ...
The Journal of clinical investigation 128 (1), 427-445, 2018
强制性开放获取政策: US National Institutes of Health, Helmholtz Association, Academy of Finland …
Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia
CC Oakes, R Claus, L Gu, Y Assenov, J Hüllein, M Zucknick, M Bieg, ...
Cancer discovery 4 (3), 348-361, 2014
强制性开放获取政策: US National Institutes of Health
BRAF inhibition in hairy cell leukemia with low-dose vemurafenib
S Dietrich, A Pircher, V Endris, F Peyrade, CM Wendtner, GA Follows, ...
Blood, The Journal of the American Society of Hematology 127 (23), 2847-2855, 2016
强制性开放获取政策: Cancer Research UK
Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations
BH Durham, B Getta, S Dietrich, J Taylor, H Won, JM Bogenberger, ...
Blood, The Journal of the American Society of Hematology 130 (14), 1644-1648, 2017
强制性开放获取政策: US Department of Defense, US National Institutes of Health, Damon Runyon …
Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia
AC Leeksma, J Taylor, B Wu, JR Gardner, J He, M Nahas, M Gonen, ...
Leukemia 33 (2), 390-402, 2019
强制性开放获取政策: US National Institutes of Health
Elucidation of tonic and activated B-cell receptor signaling in Burkitt’s lymphoma provides insights into regulation of cell survival
J Corso, KT Pan, R Walter, C Doebele, S Mohr, H Bohnenberger, ...
Proceedings of the National Academy of Sciences 113 (20), 5688-5693, 2016
强制性开放获取政策: German Research Foundation, Blood Cancer UK, UK Medical Research Council …
Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia
J Lu, E Cannizzaro, F Meier-Abt, S Scheinost, PM Bruch, HAR Giles, ...
Nature cancer 2 (8), 853-864, 2021
强制性开放获取政策: German Research Foundation, European Molecular Biology Laboratory, Helmholtz …
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
A Jahn, A Rump, TJ Widmann, C Heining, P Horak, B Hutter, ...
Annals of Oncology 33 (11), 1186-1199, 2022
强制性开放获取政策: Helmholtz Association
TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma
A Jethwa, M Słabicki, J Hüllein, M Jentzsch, V Dalal, S Rabe, L Wagner, ...
Blood, The Journal of the American Society of Hematology 131 (25), 2789-2802, 2018
强制性开放获取政策: US National Institutes of Health, Helmholtz Association, European Commission …
The protein landscape of chronic lymphocytic leukemia
F Meier-Abt, J Lu, E Cannizzaro, MF Pohly, S Kummer, S Pfammatter, ...
Blood, The Journal of the American Society of Hematology 138 (24), 2514-2525, 2021
强制性开放获取政策: European Commission, Federal Ministry of Education and Research, Germany …
Requirement for YAP1 signaling in myxoid liposarcoma
M Trautmann, YY Cheng, P Jensen, N Azoitei, I Brunner, J Hüllein, ...
EMBO molecular medicine 11 (5), e9889, 2019
强制性开放获取政策: German Research Foundation, Helmholtz Association, Swedish Research Council …
Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL
PM Bruch, HAR Giles, C Kolb, SA Herbst, T Becirovic, T Roider, J Lu, ...
Molecular Systems Biology 18 (8), e10855, 2022
强制性开放获取政策: German Research Foundation, Federal Ministry of Education and Research, Germany
出版信息和资助信息由计算机程序自动确定